IFNG and tuberculosis: Although years may pass before this possibility is formally tested in a clinical trial, and translating animal model data to human TB therapy has recognized limitations, the results from the study by Rothchild et al. (22) nonetheless provide a scientific basis for exploring GM-CSF–IFN-γ as a cytokine combination therapy for TB.